Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy
Authors:
- Yogesh Mahadu KhetmalisYKYogesh Mahadu Khetmalis
- Bakhya ShreeBSBakhya Shree
- Boddupalli Venkata Siva KumarBKBoddupalli Venkata Siva Kumar
- Markus SchweipertMSMarkus Schweipert
- Cécile DebarnotCDCécile Debarnot
- Fathima AshnaFAFathima Ashna
- Murugesan SankaranarayananMSMurugesan Sankaranarayanan
- Jamma TrinathJTJamma Trinath
- Vivek SharmaVSVivek Sharma
- Franz-Josef Meyer-AlmesFMFranz-Josef Meyer-Almes
- Kondapalli Venkata Gowri Chandra SekharKSKondapalli Venkata Gowri Chandra Sekhar
- 11 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1278
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India (392) / 21 / EMR II)
This publication has 53 references indexed in Scilit:
- Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 IsoformJournal of Medicinal Chemistry, 2013
- Development of Tetrahydroisoquinoline-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor ActivitiesJournal of Medicinal Chemistry, 2011
- Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitorsBioorganic & Medicinal Chemistry, 2010
- HDAC expression and clinical prognosis in human malignanciesCancer Letters, 2009
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic TumorigenesisCancer Research, 2008
- Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFα)‐induced apoptosis through two distinct pathways involving NF‐κB downregulation and Fas‐mediated formation of death inducing signaling complexInternational Journal of Cancer, 2008
- The aggresome pathway as a target for therapy in hematologic malignanciesMolecular Genetics and Metabolism, 2008
- Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6–Dependent Protein DegradationCancer Research, 2008
- HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPSNature, 2007
- Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylationProceedings of the National Academy of Sciences of the United States of America, 2003